Divi’s Laboratories has reported results for the first quarter ended June 30, 2020.
The company has reported a rise of 84.12% in its net profit at Rs 492.25 crore for the quarter under review as compared to Rs 267.35 crore for the same quarter in the previous year. Total income of the company increased by 47.48% at Rs 1,727.83 crore for Q1FY21 as compared Rs 1171.55 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 80.61% in its net profit attributable to shareholders at Rs 492.06 crore for the quarter under review as compared to Rs 272.44 crore for the same quarter in the previous year. Total income of the company increased by 46.48% at Rs 1747.80 crore for Q1FY21 as compared Rs 1,193.20 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1525.00 |
Dr. Reddys Lab | 5942.65 |
Cipla | 1345.35 |
Zydus Lifesciences | 925.95 |
Lupin | 1547.05 |
View more.. |